Cat.#: ACPP-1247
| Despition | GSK3 beta Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1366 | Dopamine D5 Receptor Blocking Peptide (AC1366) | 250 µg | inquiry |
| ACPP-1122 | Synthetic Membrane Nanoparticle Human Adenosine Receptor A2a Protein (AC1122) | 50 µg | inquiry |
| ACPP-1450 | Human BMP13 Protein (AC1450) | 10 µg | inquiry |
| ACPP-1591 | Mouse VCAM1 Protein (AC1591) | 2 µg | inquiry |
| ACPP-1148 | Recombinant Human NCAM1 Protein (Fc Tag) (AC1148) | 50 µg | inquiry |
| ACPP-1093 | Synthetic Nanodisc Human CCR5 Protein (AC1093) | 10 µg | inquiry |
| ACPP-1412 | Human SLC4A4 Protein (AC1412) | 5 µg | inquiry |
| ACPP-1487 | Human Pleiotrophin Protein (AC1487) | 5 µg | inquiry |
| ACPP-1562 | Human TAGLN3 Protein (AC1562) | 5 µg | inquiry |
| ACPP-1150 | Synthetic Nanodisc Human TRPV1 Protein (AC1150) | 10 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.